🔎 Trials Near Me

Home › with Excess of Blasts Refractory Anemia

with Excess of Blasts Refractory Anemia clinical trials recruiting in the U.S.

19 studies for with Excess of Blasts Refractory Anemia are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

RecruitingPhase 2
Ages 6 to 70 · All sexes · Updated Sep 28, 2026 · NCT01861106

Luspatercept + Darbepoetin in MDS

RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07096297

Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 4, 2026 · NCT03383575

Personalized NK Cell Therapy in CBT

RecruitingPhase 2
Ages 15 to 80 · All sexes · Updated Jul 30, 2026 · NCT02727803

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

RecruitingPhase 2
Up to age 60 · All sexes · Updated Jun 25, 2026 · NCT03314974

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

Recruiting
Ages 0 to 25 · All sexes · Updated May 13, 2026 · NCT05794880

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

RecruitingPhase 1/2
1 Month – 25 Years · All sexes · Updated Apr 15, 2026 · NCT06839456

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

RecruitingPhase 2
Up to age 60 · All sexes · Updated Apr 6, 2026 · NCT05735717

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

RecruitingPhase 2
Up to age 21 · All sexes · Updated Mar 13, 2026 · NCT04644016

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Dec 10, 2025 · NCT06680752

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

RecruitingPhase 2
3 Months · All sexes · Updated Nov 12, 2025 · NCT02143830

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.